SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-046825
Filing Date
2018-08-15
Accepted
2018-08-15 16:47:57
Documents
1
Period of Report
2018-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3180
  Complete submission text file 0001209191-18-046825.txt   4557
Mailing Address 200 GARRETT STREET CHARLOTTESVILLE VA 22902
Business Address 200 GARRETT STREET CHARLOTTESVILLE VA 22902 434-980-8100
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Degnan Chris (Reporting) CIK: 0001741968 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38529 | Film No.: 181021468